H3K14la drives endothelial dysfunction in sepsis‐induced ARDS by promoting SLC40A1/transferrin‐mediated ferroptosis
MedComm · 2025-02 · 6 (2)
DOI: 10.1002/mco2.70049 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm, online erschienen am 14.01.2025. Verfasst von Fangchen Gong und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai P.R. China. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Shanghai Municipal Hospital Development Center.
Themen: Sepsis
Abstract (Originalsprache)
Pulmonary endothelial cell (EC) activation is a key factor in acute respiratory distress syndrome (ARDS). In sepsis, increased glycolysis leads to lactate buildup, which induces lysine lactylation (Kla) on histones and other proteins. However, the role of protein lactylation in EC dysfunction during sepsis‐induced ARDS remains unclear. Integrative lactylome and proteome analyses were performed to identify the global lactylome profile in the lung tissues of septic mice. Cut&Tag analysis was used to identify the transcriptional targets of histone H3 lysine 14 lactylation (H3K14la) in ECs. Septic mice presented elevated levels of lactate and H3K14la in lung tissues, particularly in pulmonary ECs. Suppressing glycolysis reduced both H3K14la and EC activation, suggesting a link between glycolysis and lactylation. Moreover, H3K14la was enriched at promoter regions of ferroptosis‐related genes such as transferrin receptor (TFRC) and solute carrier family 40 member 1 (SLC40A1), which contributed to EC activation and lung injury under septic conditions. For the first time, we reported the role of lactate‐dependent H3K14 lactylation in regulating EC ferroptosis to promote vascular dysfunction during sepsis‐induced lung injury. Our findings suggest that manipulation of the glycolysis/H3K14la/ferroptosis axis may provide novel therapeutic approaches for sepsis‐associated ARDS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai P.R. China.
- Department of Critical Care Medicine Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai P.R. China.
- Department of General Surgery Ruijin Hospital Lu Wan Branch Shanghai Jiaotong University School of Medicine Shanghai P.R. China.
- Shanghai Institute of Aviation Medicine Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital Shanghai P.R. China.
ORCID-Profile: Rongli Xie
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Shanghai Municipal Hospital Development Center
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Gong, F., Zheng, X., Xu, W., Xie, R., Liu, W., Pei, L., Zhong, M., Shi, W., Qu, H., Mao, E., Yang, Z., Li, R., Chen, E., & Chen, Y. (2025). H3K14la drives endothelial dysfunction in sepsis‐induced ARDS by promoting SLC40A1/transferrin‐mediated ferroptosis. MedComm, 6(2). https://doi.org/10.1002/mco2.70049
Vancouver
Gong F, Zheng X, Xu W, Xie R, Liu W, Pei L, et al. H3K14la drives endothelial dysfunction in sepsis‐induced ARDS by promoting SLC40A1/transferrin‐mediated ferroptosis. MedComm. 2025;6(2). doi:10.1002/mco2.70049
BibTeX
@article{Gong2025,
author = {Gong, Fangchen and Zheng, Xiangtao and Xu, Wen and Xie, Rongli and Liu, Wenbin and Pei, Lei and Zhong, Ming and Shi, Wen and Qu, Hongping and Mao, Enqiang and Yang, Zhitao and Li, Ranran and Chen, Erzhen and Chen, Ying},
title = {H3K14la drives endothelial dysfunction in sepsis‐induced ARDS by promoting SLC40A1/transferrin‐mediated ferroptosis},
journal = {MedComm},
year = {2025},
volume = {6},
number = {2},
doi = {10.1002/mco2.70049}
}
EUVIMED